Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With HCV Genotype 1 Infection

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by PharmaEssentia.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
PharmaEssentia
ClinicalTrials.gov Identifier:
NCT01587586
First received: April 26, 2012
Last updated: April 27, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)